Bluejay Diagnostics, Inc. (BJDX)
NASDAQ: BJDX · Real-Time Price · USD
3.350
-0.210 (-5.90%)
At close: Jan 17, 2025, 4:00 PM
3.810
+0.460 (13.73%)
Pre-market: Jan 21, 2025, 4:23 AM EST
Bluejay Diagnostics Market Cap
Bluejay Diagnostics has a market cap or net worth of $1.80 million as of January 21, 2025. Its market cap has decreased by -19.71% in one year.
Market Cap
1.80M
Enterprise Value
-3.70M
1-Year Change
-19.71%
Ranking
Category
Stock Price
$3.35
Market Cap Chart
Since the IPO on November 10, 2021, Bluejay Diagnostics's market cap has decreased from $67.50M to $1.80M, a decrease of -97.33%. That is a compound annual growth rate of -67.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 17, 2025 | 1.80M | -31.21% |
| Dec 31, 2024 | 2.62M | 73.26% |
| Dec 29, 2023 | 1.51M | -80.26% |
| Dec 30, 2022 | 7.66M | -84.66% |
| Dec 31, 2021 | 49.91M | -26.06% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 352.70B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |